We are live on ! Find out more
BIOL

Biolase, Inc.

Delisted

BIOL was delisted on the 18th of June, 2024.

37 hedge funds and large institutions have $41.2M invested in Biolase, Inc. in 2013 Q2 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $7K | Put options by funds: $3K

Holders
37
Holders Change
+37
Holders Change %
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
Reduced
Closed
Calls
$7K
Puts
$3K
Net Calls
+$4K
Net Calls Change
+$4K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EAM
1
Eagle Asset Management
Florida
$11.8M +$15M +269 New
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$7.28M +$9.28M +166 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.41M +$5.65M +101 New
BIT
4
BlackRock Institutional Trust
California
$3.8M +$4.86M +87 New
BFA
5
BlackRock Fund Advisors
California
$2.85M +$3.63M +65 New
PCMI
6
Princeton Capital Management Inc
New Jersey
$1.71M +$2.18M +39 New
TAM
7
THB Asset Management
Connecticut
$1.6M +$2.07M +37 New
TA
8
Teton Advisors
New York
$1.21M +$1.57M +28 New
Northern Trust
9
Northern Trust
Illinois
$622K +$783K +14 New
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$456K +$559K +10 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$451K +$559K +10 New
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$438K +$559K +10 New
Morgan Stanley
13
Morgan Stanley
New York
$437K +$559K +10 New
TCIM
14
TIAA CREF Investment Management
New York
$434K +$559K +10 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$428K +$559K +10 New
PPSG
16
Princeton Portfolio Strategies Group
New Jersey
$346K +$447K +8 New
GI
17
GAMCO Investors
Connecticut
$342K +$447K +8 New
BIM
18
BlackRock Investment Management
Delaware
$300K +$391K +7 New
DCM
19
Dialectic Capital Management
Connecticut
$288K +$391K +7 New
State Street
20
State Street
Massachusetts
$223K +$280K +5 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$198K +$280K +5 New
Bank of America
22
Bank of America
North Carolina
$196K +$224K +4 New
GF
23
Gabelli Funds
New York
$166K +$224K +4 New
Charles Schwab
24
Charles Schwab
California
$162K +$224K +4 New
TA
25
Teachers Advisors
New York
$145K +$168K +3 New

BIOL Hedge Fund Activity: Q2 2013 in Review

37 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2013, worth a combined $41.2M.

Buyers outnumbered sellers: 37 funds opened new BIOL positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

  • 37 institutional investors held Biolase, Inc. (BIOL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $41.2M of Biolase, Inc. stock for Q2 2013.
  • 37 funds opened new Biolase, Inc. positions in Q2 2013 and 0 closed out, a net change of +37 holders.

Based on aggregated 13F filings for Q2 2013.